We previously generated a highly thermostable triple variant of Moloney murine leukemia virus reverse transcriptase, MM3 (E286R/E302K/L435R), by introducing positive charges by site-directed mutagenesis at positions that have been implicated in the interaction with template-primer (Yasukawa et al., (2010) J. Biotechnol., 150,[299][300][301][302][303][304][305][306]. In this study, we attempted to further increase the thermostability of MM3. Twenty-nine mutations were newly designed, focusing on the number of surface charge, stabilization of hydrophobic core, and introduction of salt bridge. The corresponding 29 single variants were produced in Escherichia coli and characterized for activity and stability. Six mutations (A32V, L41D, L72R, I212R, L272E and W388R) were selected as the candidates for further stabilize MM3. Fifteen multiple variants were designed by combining two or more of the six mutations with the MM3 mutations, produced and characterized. The sextuple variant MM3.14 (A32V/L72R/E286R/E302K/W388R/L435R) exhibited higher thermostability than MM3.
Introduction
Reverse transcriptase (RT) [EC 2.7.7.49 ] is the enzyme responsible for RNA viral genome replication. It possesses RNA-and DNAdependent DNA polymerase and RNase H activities. RTs from Moloney murine leukemia virus (MMLV) and avian myeloblastosis virus (AMV) are widely used in cDNA synthesis because they have high catalytic activity and fidelity (Kimmel and Berger, 1987; Roberts et al., 1988) . RT is also used in RNA-specific amplification, an isothermal reaction (41-43°C) that specifically amplifies a target RNA sequence, with RNA polymerase (Kievits et al., 1991; Ishiguro et al., 2003; Yasukawa et al., 2010a) . RT from human immunodeficiency virus type 1 (HIV-1) is mainly used as a target in the development of inhibitors for the treatment of HIV-1 infection, although recent reports have shown that it can also be used in cDNA synthesis (Barrioluengo et al., 2011; Álvarez et al., 2013; Konishi et al., 2013) . MMLV RT is a 75-kDa monomer ( Supplementary  Fig. S1 ), while AMV RT is a heterodimer consisting of a 63-kDa α and a 95-kDa β subunits, and HIV-1 RT is a heterodimer consisting of a 66-kDa p66 and a 51-kDa p51 subunits. MMLV RT, the α subunit of AMV RT, and the p66 subunit of HIV-1 RT consists of fingers, palm, thumb, connection and RNase H domains (Patel et al., 1995; Georgiadis et al., 1995; Das and Georgiadis, 2004; Lim et al., 2006; Cote and Roth, 2008) . The β subunit of AMV RT consists of these five domains and the C-terminal integrase domain, and the p51 subunit of HIV-1 RT consists of the fingers, palm, thumb and connection subdomains. These three RTs have two active sites, one in the fingers/palm/thumb domain for the DNA polymerase reaction and the other in the RNase H domain for the RNase H reaction.
Since high reaction temperature reduces RNA secondary structures and non-specific primer binding, it is desirable in cDNA synthesis. However, RT is thermolabile. Improvement of the thermostability of RT has been an important subject. The thermostabilities of MMLV RT (Kotewicz et al., 1985; Gerard et al., 2002; Mizuno et al., 2010) , AMV RT (Gerard et al., 2002) and HIV-1 RT (Nishimura et al., 2013) were improved by eliminating the RNase H activity. We improved the thermostability of MMLV RT by sitedirected mutagenesis and generated MM3 (E286R/E302K/L435R) in which negatively charged or hydrophobic residues thought to interact with a template-primer were replaced with positively charged ones (Yasukawa et al., 2010b) and V433R in which Val433 at the molecular surface was replaced with Arg (Konishi et al., 2014) . Others improved it by random mutagenesis, in which filter assay (Arezi and Hogrefe, 2009 ) and emulsion PCR (Baranauskas et al., 2012) were used for the screening of MMLV RT with higher thermostability.
In this study, we attempted to further increase the thermostability of MMLV RT by stabilizing hydrophobic core, introducing salt bridge and increasing surface charge. The results have shown that the sextuple variant MM3.14 (A32V/L72R/E286R/E302K/W388R/ L435R) exhibited higher thermostability than MM3.
Materials and Methods

Materials
Protein concentration of RT was determined according to the method of Bradford (Bradford, 1976) using Protein Assay CBB Solution (Nacalai Tesque, Kyoto, Japan) with bovine serum albumin (Nacalai Tesque) as a standard. Standard RNA, which was an RNA of 1014-nucleotides corresponding to DNA sequence 8353-9366 of the cesA gene of Bacillus cereus (GenBank accession number DQ360825), was prepared by in vitro transcription (Yasukawa et al., 2010a) 
Construction of plasmids
Nucleic acid and protein sequences of MMLV RT is shown in Supplementary Fig. S1 . The expression plasmid for the wild-type MMLV RT, pET-MRTHis ( Supplementary Fig. S2 ), was constructed as described previously . Briefly, the 2002-bp DNA fragment encoding MMLV RT was amplified from the pUC19 plasmid that contains the complete MMLV gene (8332 bp) (GenBank accession no. J02255), using the primers 5′-AAGGAGATATACATATGACATGGCTGTCTG-3′ and 5′-CTG AATTCTAGTGGTGATGGTGGTGGTGGAGGAGGGTAGAGG TGTCT-3′ (NdeI and EcoRI sites are underlined), and the amplified DNA were digested with NdeI and EcoRI, and inserted in pET-22b (+). Expression plasmids of MMLV RT variants were constructed by site-directed mutagenesis using the pET-MRTHis or that for the thermostable variant MM3, pET-MM3 as a template and an E. coli
The primer sequences are shown in Table S1 . The nucleotide sequences of mutated MMLV RT genes were verified.
Expression and purification of single variants
Three millilitre of litre broth containing 50 μg/ml ampicillin was inoculated with the glycerol stock of the transformed BL21(DE3) and incubated for 16 h with shaking at 30°C. The expression of the RT gene was induced using the auto-induction system (Novagen, Darmstadt, Germany). MMLV RT was purified from culture medium using HisLink Spin Protein Purification System (Promega, Madison, WI). Briefly, the bacterial cells were disrupted by FastBreak Cell Lysis Reagent, followed by addition of HisLink Protein Purification Resin to the culture. The samples were then transferred to HisLink Spin Column where unbound protein was washed away. MMLV RT was recovered by the elution with 0.2 ml of 100 mM HEPES-NaOH buffer (pH 7.5), 500 mM imidazole. The active fraction was desalted using pre-packed PD-10 gel filtration columns (GE Healthcare, Buckinghamshire, UK) equilibrated with 50 mM Tris-HCl buffer (pH 8.3), 200 mM KCl and 50% glycerol. The RT preparation thus obtained was stored at −80°C.
Expression and purification of multiple variants
The overnight culture of the transformants (5 ml) was added to 500 ml of litre broth containing ampicillin (50 μg/ml) and incubated with shaking at 37°C. When OD 660 reached 0.6-0.8, 0.15 ml of 0.5 M IPTG was added and growth was continued at 30°C for 3 h. After centrifugation at 10 000 × g for 5 min, the cells were suspended with 10 ml of 0.02 M potassium phosphate buffer (pH 7.2), 2.0 mM dithiothreitol (DTT), 10% glycerol (buffer A) containing 10 mM phenylmethylsulfonyl fluoride and disrupted by sonication. After centrifugation at 20 000 × g for 40 min, the supernatant was collected and applied to a column [25 mm (inner diameter) × 120 mm] packed with Toyopearl DEAE-650 M gel (Tosoh, Tokyo, Japan) equilibrated with buffer A. After the washing with buffer A containing 120 mM NaCl, the bound RT was eluted with buffer A containing 300 mM NaCl. Solid (NH 4 ) 2 SO 4 was added to the eluate (30 mL) to a final concentration of 40% saturation. The solution was stirred for 5 min and left for 30 min on ice. After centrifugation at 20 000 × g for 30 min at 4°C, the precipitate was collected and dissolved in 10 ml of buffer A containing 100 mM NaCl. The solution was applied to the column packed with a Ni 2+ -sepharose (HisTrap HP 1 ml, GE Healthcare) equilibrated with 50 mM TrisHCl buffer (pH 8.3), 200 mM KCl, 2 mM DTT, 10% glycerol (buffer B). After the washing with buffer B containing 50 mM imidazole, the bound RT was eluted with buffer B containing 500 mM imidazole. The active fraction was desalted using pre-packed PD-10 gel filtration columns equilibrated with 50 mM Tris-HCl buffer (pH 8.3), 200 mM KCl, 50% glycerol and stored at −80°C.
SDS-PAGE
SDS-polyacrylamide gel electrophoresis (PAGE) was performed in a 10% polyacrylamide gel under reducing conditions. Proteins were reduced by treatment with 2.5% of 2-mercaptoethanol at 100°C for 10 min, and then applied onto the gel. A constant current of 40 mA was applied for 40 min. After electrophoresis, proteins were stained with Coomassie Brilliant Blue R-250. The molecular mass marker kit consisting of pig myosin (200 kDa), E. coli β-galactosidase (116 kDa), rabbit muscle phosphorylase B (97.2 kDa), bovine serum albumin (66.4 kDa), hen egg white ovalbumin (44.3 kDa) and bovine carbonic anhydrase (29.0 kDa) was a product of Takara Bio Inc (Otsu, Japan).
Reverse transcription assay using [ 3 H]-dTTP
Poly ( 16 for use in thermal inactivation was prepared as follows: poly (rA) (3 μl of 1 mg/ml in 100 mM Tris-HCl buffer (pH 8.1), 0.5 mM EDTA) and p(dT) 16 (3 μl of 50 μg/ml in 100 mM Tris-HCl buffer (pH 8.1), 0.5 mM EDTA) were mixed and left for 1 h at room temperature followed by the dilution with 114 μl of PDGT (0.01 M potassium phosphate buffer (pH 7.6), 2 mM DTT, 10% glycerol, 0.2% Triton X-100). MMLV RT (8 μl of 500 nM), poly(rA)-p(dT) 16 (8 μl) and PDGT (64 μl) were mixed to make the MMLV RT concentration 50 nM. To estimate the denaturation, the resulting solution (40 μl out of 80 μl) was incubated at 49 or 51°C for 10 min followed by the incubation on ice for 30 min. Poly(rA)-p(dT) 16 for use in reverse transcription assay was prepared as follows: poly(rA) (5 μl) and p(dT) 16 (5 μl) were mixed and left for 1 h at room temperature followed by the dilution with 2 ml of polymerization buffer (60 mM Tris-HCl buffer (pH 8.1), 60 mM KCl, 8 mM MgCl 2 , 13 mM DTT, 100 μM dTTP). Poly(rA)-p(dT) 16 (96 μl) and 40 μl of 50 nM MMLV RT, either exposed to the thermal treatment or not, were incubated at 37°C for 10 min. The reaction was initiated by adding the pre-incubated MMLV RT solution (24 μl out of 40 μl) to the pre-incubated poly(rA)-p(dT) 16 solution (96 μl). An aliquot (25 μl) was taken from the reaction mixture at 2.5, 5.0, 7.5 and 10 min, to which 2 μl of 200 mM EDTA was immediately added, followed by the incubation on ice for 30 min or more. Blank solution was prepared by mixing poly(rA)-p(dT) 16 solution (20 μl) and 200 mM EDTA (2 μl) followed by the addition of MMLV RT solution (5 μl). To each solution (27 μl), PicoGreen solution (173 μl) was added. The tubes were wrapped with aluminum foil and left at room temperature for 10 min. The fluorescence at 523 nm was measured with EnSight (PerkinElmer, Waltham, MA) with the excitation wavelength of 502 nm.
cDNA synthesis
The ces RNA, which is an RNA of 1014-nucleotides corresponding to DNA sequence 8353-9366 of the cesA gene of Bacillus cereus (GenBank accession number DQ360825), was prepared by in vitro transcription. The reaction mixture for cDNA synthesis (20 μl) was prepared by mixing water (12 μl), 10 × RT buffer (250 mM TrisHCl buffer (pH 8.3), 500 mM KCl, 20 mM DTT, 50 mM MgCl 2 ) (2 μL), 2.0 mM dNTP (1 μL), 160 pg/μl cesA RNA (2 μl), 10 μM RV-R26 primer 5′-TGTGGAATTGTGAGCGGTGTCGCAATCACCG TAACACGACGTAG-3′ (1 μl) and 10 nM MMLV RT WT (2 μl).
The reaction was run at 45°C for 30 min and 65°C for 5 min. The reaction mixture for PCR (25 μl) was prepared by mixing the reaction product of cDNA synthesis (2 μl), water (17.7 μl), 10 × PCR buffer (2.5 μl), 2 mM dNTP (1.5 μl), 10 μM F5 primer 5′-TGCGCG CAAAATGGGTATCAC-3′ (0.5 μl) and 10 μM RV primer 5′-TG TGGAATTGTGAGCGG-3′ (0.5 μl), and Taq polymerase (0.3 μl). The reaction was run under 30 cycles of 30 s at 95°C, 30 s at 55°C and 60 s at 72°C. The amplified products was separated on 1.0% w/v agarose gels and stained with ethidium bromide (1 μg/ml). 6.2 ± 0.7 (0.44) 9.1 ± 0.8 6.3 ± 2.1 V118I 3.7 ± 0.1 (0.27) 59.5 ± 1.1 17.8 ± 0.9 Y146F 3.9 ± 0.8 (0.28) 58.7 ± 7.6 24.5 ± 10.0 A154I
1.2 ± 0.2 (0.09) NT NT I261F 0.7 ± 0.2 (0.05) NT NT C310L 3.6 ± 0.1 (0.26) 67.0 ± 3.2 32.8 ± 0.3 D361L 2.8 ± 0.3 (0.20) 54.2 ± 12.2 31.6 ± 7.6 (iii) Introduction of salt bridge L41D 21.3 ± 0.2 (1.5) 12.6 ± 0 2.0 ± 0.5 Q63E 7.2 ± 0.6 (0.51) 33.7 ± 2.6 5.5 ± 0.5 L272E 7.4 ± 0 (0.53) 72.6 ± 0.3 31.7 ± 1.0 W336R 1.8 ± 0.5 (0.13) 56.7 ± 2.6 40.6 ± 3.3 I347E
1.5 ± 0.3 (0.11) 60.2 ± 24.5 82.0 ± 8.7 L357D 0.9 ± 0. 
Results and Discussion
Design of mutation and evaluation of thermostabilities of single variants
In MMLV RT, crystal structure of the fingers, palm, thumb and connection domains (Thr24-Pro474) (Das and Georgiadis, 2004 ) and that of the RNase H domain (His503-Ser668) (Lim et al., 2006) have been independently determined. The former was determined from the crystal of the full length MMLV RT (Thr24-Leu671) (PDB accession code 1RW3). Based on this structure, we designed 29 mutations (Table I) : (i) Ten hydrophobic residues (V43, L72, M177, I179, I212, L234, M289, L351, L368 and L410) located in the molecular surface were selected and ten mutations aimed to increase surface charge were designed; (ii) Eight hydrophobic or polar residues (A32, A42, V118, Y146, A154, I261, C310 and D361) located in the inner part were selected and eight mutations aimed to stabilize hydrophobic core were designed; (iii) Eight hydrophobic or polar residues (L41, Q63, L272, W336, I347, L357, V370 and W388) located close to positively (Lys, Arg) or negatively (Asp, Glu) charged residues were selected and eight mutations aimed to introduce salt bridge were designed and (iv) Three Cys residues (C90, C262 and C409) were selected and three mutations aimed to avoid the formation of disulfide bond were designed. The wild-type MMLV RT (WT) and variants were expressed in 3-ml culture and purified from the cells. The thermostable quadruple variant, MM4 (E286R/E302K/L435R/D524A) in which the catalytic residue for the RNase H activity, Asp524 was mutated and thus lacks RNase H activity (Yasukawa et al., 2010b) , was also prepared. Following SDS-PAGE under reducing conditions, all enzyme preparations yielded a single band with a molecular mass of 75 kDa (data not shown). Table I shows the specific activities of the reverse transcription reaction for WT and the 29 variants. The specific activity of WT was 14 000 units/mg. All variants can be classified into three groups. Group 1 comprises V43E, A154I, I261F, L357D, L368R and V370E whose specific activities were less than 10% of that of WT. Group 2 comprises A32V, L41D, Q63E, L72R, L272E W388R and L410R whose specific activities were 50-150% of that of WT. Group 3 comprises the other 16 variants whose specific activities were 10-50% of that of WT. Table I also shows the remaining activity after the incubation at 46 or 49°C, respectively, of WT, MM4 and the 23 variants which belong to Group 2 or 3. Relative activity was defined as the ratio of the initial reaction rate for a 10-min incubation at 46 or 49°C in the presence of template-primer (T/P) to the rate without incubation. The remaining activities of WT and MM4 at 46°C were 67 and 122%, and those at 49°C were 15 and 102%, respectively. No variants exhibited higher than MM4. However, A32V, L72R, I212R, L272E, W388R and C409R exhibited higher remaining activity than WT at 46 and 49°C.
Design of mutational combination and characterization of thermostabilities of multiple variants
In various enzymes, a variety of mutations which enhance catalytic activity or thermostability have been identified by site-directed mutagenesis and random mutagenesis (Eijsink et al., 2004; CobuccPonzano et al., 2011) . If the effects of these mutations were additive, a variant enzyme with multiple mutations would have more desirable properties. However, it is generally known that there is a trade-off between activity and stability in various enzymes: mutations which increase enzyme activity accompany decrease in protein stability, and those which increase protein stability do decrease in enzyme activity (Shoichet et al., 1995) . In addition, it is not easy presently to predict the effect of mutational combination on enzyme properties.
Based on the results presented in Table I , five mutations (A32V, L72R, I212R, L272E and W388R) were selected as the stabilizing Table II . Activity and stability of multiple variants by the assay using 9.2 ± 1.1 (0.66) 52.8 ± 2.8 26.5 ± 0.8 MM3.1 (E286R/E302K/W388R/L435R) 3.9 ± 0.1 (0.28) 32.
11.2 ± 1.3 (0.81) 62.7 ± 3.2 40.9 ± 1.5 MM3.6 (L41D/E286R/E302K/L435R) 10.3 ± 0.9 (0.74) 14.9 ± 0.5 NT MM3.7 (I212R/E286R/E302K/W388R/L435R) 14.7 ± 0.6 (1.1) 73.0 ± 0.3 76.9 ± 7.9 MM3.8 (L72R/E286R/E302K/W388R/L435R) 8.4 ± 0.1 (0.60) 89.4 ± 1.3 62.9 ± 4.8 MM3.9 (L72R/I212R/E286R/E302K/L435R) 8.0 ± 0.2 (0.58) 71.0 ± 1.3 29.7 ± 0.8 MM3.10 (L72R/I212R/E286R/E302K/W388R/L435R) 6.0 ± 0.1 (0.43) 96.6 ± 4.6 45.3 ± 0.6 MM3.11 (A32V/L72R/E286R/E302K/L435R) NT NT NT MM3.12 (A32V/I212R/E286R/E302K/L435R) 11.2 ± 0.2 (0.81) 0.1 ± 1.2 1.2 ± 1.0 MM3.13 (A32V/I212R/E286R/E302K/W388R/L435R) 9.5 ± 1.1 (0.68) 2.2 ± 1.3 4.5 ± 0.8 MM3.14 (A32V/L72R/E286R/E302K/W388R/L435R) 14.4 ± 1.6 (1.04) 44.5 ± 1.4 32.0 ± 0.4 M3.15 (A32V/L72R/I212R/E286R/E302K/W388R/L435R) 14.8 ± 0.7 (1.06) 27.6 ± 0.6 9.7 ± 1. mutations and one mutation (L41D) was selected as the activating mutation. C409R was not selected because its specific activity was low. First, six variants (MM3.1-MM3.6) were designed by combining one out of the six mutations with the MM3 mutations (E286R, E302K and L435R) (Table II) . These six variants were expressed in E. coli and purified from the cells. Upon SDS-PAGE under reducing conditions, purified variants yielded a single band with a molecular mass of 75 kDa (Fig. S3) . The yields of the purified enzyme preparations from 500 ml of culture were in the range of 0.38-4.26 mg, which were comparable to that of the WT (2.27 mg). Table II shows the activities and stabilities of WT and variants by the reverse transcription assay using [ 3 H]-dTTP, and Table III shows their stabilities by the assay using fluorescent dye PicoGreen. The remaining activities of MM3.3 and MM3.5 were higher than that of MM3. MM3.2 (L272E/E286R/E302K/L435R) lacked the activity (Table II) , and the remaining activity of MM3.6 (L41D/E286R/ E302K/L435R) was the lowest (Table II) , indicating that the mutations of L272E and L41D were incompatible with the MM3 mutations. Next, four variants (MM3.7-MM3.10) were designed by combining two or three out of the three mutations (L72R, I212R and W388R) with the MM3 mutations (Table II) and prepared ( Fig. S3 and Table II ). The remaining activities of MM3.7, MM3.8, MM3.9 and MM3.10 were comparable to that of MM3 (Tables II and III) .
Finally, five variants (MM3.11-MM3.15) were designed by combing two or more of the four mutations (A32V, L72R, I212R, and W388R) (Table II) . MM3.11 was not expressed, while the other four variants (MM3.12-MM3.15) were expressed in E. coli and purified. Tables II and III show their stabilities as assessed by the assay using [ 3 H]-dTTP and PicoGreen, respectively. The remaining activity of MM3.14 was comparable to that of MM3 while those of MM3.12, MM3.13 and MM3.15 were lower than MM3.
MM3.14 was further evaluated for stability. Figure 1 shows the comparison of the thermostabilities of WT, MM3 and MM3.14. The cDNA synthesis reaction was carried out at 45°C for 30 min with WT, MM3 or MM3.14 exposed to 48-63°C for 10 min. The reaction products were subjected to PCR, followed by agarose gel electrophoresis. The highest temperatures at which cDNA was synthesized were 60°C for MM3 and MM3.14, indicating that the thermostability of MM3.14 was comparable to that of MM3. Figure 2 shows the temperature dependence on cDNA synthesis by WT, MM3 or MM3.14. After the cDNA synthesis reaction, real-time PCR was carried out. When cDNA synthesis reaction was conducted with MM3.14 at 55, 60 or 65°C for 10 min, the fluorescence increased in the PCR. On the other hand, when the cDNA synthesis reaction was conducted with WT or MM3, it was not. This indicates that MM3.14 was more thermostable and more suitable for use in cDNA synthesis than MM3. However, it should be noted that the effects of the three mutations (A32V/ L72R/W388R) on the stability of MM3 (E286R/E302K/L435R) did not seem large. 6.0 ± 0.5 4.1 ± 0.2 (0.69) NT MM3.4 (L72R/E286R/E302K/L435R) 8.9 ± 0.6 6.3 ± 0.5 (0.71) NT MM3.5 (I212R/E286R/E302K/L435R) 13.1 ± 1.1 7.5 ± 0.8 (0.58) NT MM3.6 (L41D/E286R/E302K/L435R) 11.0 ± 1.1 2.2 ± 0.1 (0.20) NT MM3.7 (I212R/E286R/E302K/W388R/L435R) 11.1 ± 0.4 7.1 ± 0.6 (0.64) NT MM3.8 (L72R/E286R/E302K/W388R/L435R) 8.9 ± 0.9 5.5 ± 0.4 (0.62) NT MM3.9 (L72R/I212R/E286R/E302K/L435R) 9.5 ± 0. RT at 50 nM was incubated at 49 or 51°C in the presence of poly(rA)-p(dT) 16 (0.5 μM) for 10 min. Then, the dTTP incorporation reaction was carried out at 37°C. c Numbers in parentheses indicate the relative activity, which is defined as the ratio of the initial reaction rate with incubation to that without incubation. Temperature for heat treatment (ºC) Fig. 1 Stability of WT, MM3 or MM3.14 as assessed by cDNA synthesis. RT at 10 nM was incubated at 48, 54, 57, 60 or 63°C for 10 min. Then, the cDNA synthesis was carried out with 16 pg/μl cesA RNA, 1 μM RV-R26 primer at 45°C for 30 min. PCR was carried out with a primer combination of RV and F5. Amplified products were applied to 1% agarose gel followed by staining with ethidium bromide (1 μg/ml).
